Personalized prediction for a 69 year old man who takes Liothyronine Sodium, Vitamins, Metformin Hydrochloride, Levothyroxine Thyroid, Alfuzosin Hydrochloride, Lovastatin, Creon, Mirtazapine, Pantoprazole, Simethicone, Cetirizine Hydrochloride Allergy, Salviae Miltiorrhizae, Peppermint Oil, Tadalafil, Aspirin (an AI-powered real world drug study)

Summary:

This is a personalized prediction of potential side effects and undetected conditions for up to one year, if you would have adverse effects. The study is created by eHealthMe based on data from the FDA.

What are the drugs?

What are the conditions?

Preventative: no further information found.
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development) is found to be associated with 1,626 drugs and 2,556 conditions by eHealthMe. Check the latest studies of Hypothyroidism.
Type i lipidaemia (abnormally elevated levels of any or all lipids and/or lipoproteins in the blood- type i) is found to be associated with 1 drug by eHealthMe. Check the latest studies of Type i lipidaemia.
Exocrine pancreatic function test abnormal is found to be associated with 3 drugs and 16 conditions by eHealthMe. Check the latest studies of Exocrine pancreatic function test abnormal.
Gerd (gastro-oesophageal reflux disease) is found to be associated with 3,426 drugs and 3,415 conditions by eHealthMe. Check the latest studies of Gerd.
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters) is found to be associated with 1,600 drugs and 1,903 conditions by eHealthMe. Check the latest studies of Eczema.
Gas is found to be associated with 4 conditions by eHealthMe. Check the latest studies of Gas.
Reflux (stomach contents come back up into the food pipe (gullet or oesophagus) or even into the mouth) is found to be associated with 2,593 drugs and 3,433 conditions by eHealthMe. Check the latest studies of Reflux.
Bph is found to be associated with 1,000 drugs and 1,376 conditions by eHealthMe. Check the latest studies of Bph.
Depression post-operative is found to be associated with 3 drugs and 20 conditions by eHealthMe. Check the latest studies of Depression post-operative.

What are the symtoms?

Gerd (gastro-oesophageal reflux disease) is found to be associated with 3,426 drugs and 3,415 conditions by eHealthMe. Check the latest studies of Gerd.
Exocrine pancreatic function test abnormal is found to be associated with 3 drugs and 16 conditions by eHealthMe. Check the latest studies of Exocrine pancreatic function test abnormal.
Bph is found to be associated with 1,000 drugs and 1,376 conditions by eHealthMe. Check the latest studies of Bph.
Esophageal cancer: no further information found.
Psoriasis aggravated (immune-mediated disease that affects the skin) is found to be associated with 1,295 drugs and 451 conditions by eHealthMe. Check the latest studies of Psoriasis aggravated.
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development) is found to be associated with 1,626 drugs and 2,556 conditions by eHealthMe. Check the latest studies of Hypothyroidism.
Depression is found to be associated with 3,224 drugs and 4,058 conditions by eHealthMe. Check the latest studies of Depression.

Potential side effects:

Bladder cancer

8.35% for males aged 69 (±5) who have reflux and preventative
8.35% for males aged 69 (±5) who have gerd and exocrine pancreatic function test abnormal
8.35% for males aged 69 (±5) who have gerd and type i lipidaemia
8.35% for males aged 69 (±5) who have gerd and reflux
8.35% for males aged 69 (±5) who have gerd and gas
8.35% for males aged 69 (±5) who have gerd and depression post-operative
8.35% for males aged 69 (±5) who have gerd and preventative
8.35% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and reflux
8.35% for males aged 69 (±5) who have type i lipidaemia and reflux
8.35% for males aged 69 (±5) who have reflux and gas
8.35% for males aged 69 (±5) who have reflux and depression post-operative
8.03% for males aged 69 (±5) who have gerd and eczema
8.03% for males aged 69 (±5) who have reflux and eczema
7.14% for males aged 69 (±5) who have gerd and hypothyroidism
7.14% for males aged 69 (±5) who have reflux and hypothyroidism
6.28% for males aged 69 (±5) who have gerd and bph
6.28% for males aged 69 (±5) who have bph and reflux

Chronic kidney disease

7.41% for males aged 69 (±5) who have reflux and depression post-operative
7.41% for males aged 69 (±5) who have reflux and preventative
7.41% for males aged 69 (±5) who have gerd and exocrine pancreatic function test abnormal
7.41% for males aged 69 (±5) who have gerd and type i lipidaemia
7.41% for males aged 69 (±5) who have gerd and reflux
7.41% for males aged 69 (±5) who have gerd and gas
7.41% for males aged 69 (±5) who have gerd and depression post-operative
7.41% for males aged 69 (±5) who have gerd and preventative
7.41% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and reflux
7.41% for males aged 69 (±5) who have type i lipidaemia and reflux
7.41% for males aged 69 (±5) who have reflux and gas
7.13% for males aged 69 (±5) who have gerd and eczema
7.13% for males aged 69 (±5) who have reflux and eczema
6.4% for males aged 69 (±5) who have gerd and hypothyroidism
6.4% for males aged 69 (±5) who have reflux and hypothyroidism
5.54% for males aged 69 (±5) who have gerd and bph
5.54% for males aged 69 (±5) who have bph and reflux

Death

5.27% for males aged 69 (±5) who take liothyronine sodium
5.27% for males aged 69 (±5) who take vitamins
5.27% for males aged 69 (±5) who take cetirizine hydrochloride allergy
5.27% for males aged 69 (±5) who take salviae miltiorrhizae
5.27% for males aged 69 (±5) who take peppermint oil
5.27% for males aged 69 (±5) who take tadalafil
5.27% for males aged 69 (±5) who take aspirin
5.27% for males aged 69 (±5) who take metformin hydrochloride
5.27% for males aged 69 (±5) who take levothyroxine thyroid
5.27% for males aged 69 (±5) who take alfuzosin hydrochloride
5.27% for males aged 69 (±5) who take lovastatin
5.27% for males aged 69 (±5) who take creon
5.27% for males aged 69 (±5) who take mirtazapine
5.27% for males aged 69 (±5) who take pantoprazole
5.27% for males aged 69 (±5) who take simethicone

Diarrhea

5.86% for males aged 69 (±5) who have hypothyroidism and gas
5.86% for males aged 69 (±5) who have hypothyroidism and depression post-operative
5.86% for males aged 69 (±5) who have hypothyroidism and preventative
5.86% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and hypothyroidism
5.86% for males aged 69 (±5) who have type i lipidaemia and hypothyroidism
5.5% for males aged 69 (±5) who have hypothyroidism and eczema

Drug ineffective

5.84% for males aged 69 (±5) who have bph and eczema
5.82% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and bph
5.82% for males aged 69 (±5) who have bph and type i lipidaemia
5.82% for males aged 69 (±5) who have bph and gas
5.82% for males aged 69 (±5) who have bph and depression post-operative
5.82% for males aged 69 (±5) who have bph and preventative
5.8% for males aged 69 (±5) who have eczema and gas
5.8% for males aged 69 (±5) who have eczema and depression post-operative
5.8% for males aged 69 (±5) who have eczema and preventative
5.8% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and eczema
5.8% for males aged 69 (±5) who have type i lipidaemia and eczema
5.26% for males aged 69 (±5) who have bph and hypothyroidism

Eczema

11.96% for males aged 69 (±5) who have eczema and gas
11.96% for males aged 69 (±5) who have eczema and depression post-operative
11.96% for males aged 69 (±5) who have eczema and preventative
11.96% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and eczema
11.96% for males aged 69 (±5) who have type i lipidaemia and eczema

Fatigue

5.99% for males aged 69 (±5) who have hypothyroidism and gas
5.99% for males aged 69 (±5) who have hypothyroidism and depression post-operative
5.99% for males aged 69 (±5) who have hypothyroidism and preventative
5.99% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and hypothyroidism
5.99% for males aged 69 (±5) who have type i lipidaemia and hypothyroidism
5.47% for males aged 69 (±5) who have hypothyroidism and eczema

Injection site pain

5.01% for males aged 69 (±5) who have eczema and gas
5.01% for males aged 69 (±5) who have eczema and depression post-operative
5.01% for males aged 69 (±5) who have eczema and preventative
5.01% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and eczema
5.01% for males aged 69 (±5) who have type i lipidaemia and eczema

Itching

10.03% for males aged 69 (±5) who have eczema and gas
10.03% for males aged 69 (±5) who have eczema and depression post-operative
10.03% for males aged 69 (±5) who have eczema and preventative
10.03% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and eczema
10.03% for males aged 69 (±5) who have type i lipidaemia and eczema

Prostate cancer

12.86% for males aged 69 (±5) who have reflux and preventative
12.86% for males aged 69 (±5) who have gerd and exocrine pancreatic function test abnormal
12.86% for males aged 69 (±5) who have gerd and type i lipidaemia
12.86% for males aged 69 (±5) who have gerd and reflux
12.86% for males aged 69 (±5) who have gerd and gas
12.86% for males aged 69 (±5) who have gerd and depression post-operative
12.86% for males aged 69 (±5) who have gerd and preventative
12.86% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and reflux
12.86% for males aged 69 (±5) who have type i lipidaemia and reflux
12.86% for males aged 69 (±5) who have reflux and gas
12.86% for males aged 69 (±5) who have reflux and depression post-operative
12.36% for males aged 69 (±5) who have gerd and eczema
12.36% for males aged 69 (±5) who have reflux and eczema
10.99% for males aged 69 (±5) who have gerd and hypothyroidism
10.99% for males aged 69 (±5) who have reflux and hypothyroidism
9.92% for males aged 69 (±5) who have gerd and bph
9.92% for males aged 69 (±5) who have bph and reflux

Rashes

10.82% for males aged 69 (±5) who have eczema and gas
10.82% for males aged 69 (±5) who have eczema and depression post-operative
10.82% for males aged 69 (±5) who have eczema and preventative
10.82% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and eczema
10.82% for males aged 69 (±5) who have type i lipidaemia and eczema

Weakness

5.62% for males aged 69 (±5) who have hypothyroidism and gas
5.62% for males aged 69 (±5) who have hypothyroidism and depression post-operative
5.62% for males aged 69 (±5) who have hypothyroidism and preventative
5.62% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and hypothyroidism
5.62% for males aged 69 (±5) who have type i lipidaemia and hypothyroidism

Potential co-existing conditions:

Abdominal discomfort

9.56% for males aged 69 (±5) who have type i lipidaemia and reflux
9.56% for males aged 69 (±5) who have reflux and gas
9.56% for males aged 69 (±5) who have reflux and depression post-operative
9.56% for males aged 69 (±5) who have reflux and preventative
9.56% for males aged 69 (±5) who have gerd and exocrine pancreatic function test abnormal
9.56% for males aged 69 (±5) who have gerd and type i lipidaemia
9.56% for males aged 69 (±5) who have gerd and reflux
9.56% for males aged 69 (±5) who have gerd and gas
9.56% for males aged 69 (±5) who have gerd and depression post-operative
9.56% for males aged 69 (±5) who have gerd and preventative
9.56% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and reflux
9.19% for males aged 69 (±5) who have reflux and eczema
9.19% for males aged 69 (±5) who have gerd and eczema
8.18% for males aged 69 (±5) who have reflux and hypothyroidism
8.18% for males aged 69 (±5) who have gerd and hypothyroidism
7.11% for males aged 69 (±5) who have gerd and bph
7.11% for males aged 69 (±5) who have bph and reflux

Atrial fibrillation/flutter

6.62% for males aged 69 (±5) who have bph and gas
6.62% for males aged 69 (±5) who have bph and depression post-operative
6.62% for males aged 69 (±5) who have bph and preventative
6.62% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and bph
6.62% for males aged 69 (±5) who have bph and type i lipidaemia
6.33% for males aged 69 (±5) who have bph and eczema

Constipation

5.63% for males aged 69 (±5) who have type i lipidaemia and eczema
5.63% for males aged 69 (±5) who have eczema and gas
5.63% for males aged 69 (±5) who have eczema and depression post-operative
5.63% for males aged 69 (±5) who have eczema and preventative
5.63% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and eczema

Dermatitis atopic

14.69% for males aged 69 (±5) who have type i lipidaemia and eczema
14.69% for males aged 69 (±5) who have eczema and gas
14.69% for males aged 69 (±5) who have eczema and depression post-operative
14.69% for males aged 69 (±5) who have eczema and preventative
14.69% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and eczema

Eczema

100.0% for males aged 69 (±5) who have type i lipidaemia and eczema
100.0% for males aged 69 (±5) who have eczema and gas
100.0% for males aged 69 (±5) who have eczema and depression post-operative
100.0% for males aged 69 (±5) who have eczema and preventative
100.0% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and eczema

Emphysema

5.19% for males aged 69 (±5) who have gerd and depression with exocrine pancreatic function test abnormal and bph
5.19% for males aged 69 (±5) who have gerd and depression with bph and type i lipidaemia
5.19% for males aged 69 (±5) who have gerd and depression with bph and gas
5.19% for males aged 69 (±5) who have gerd and depression with bph and depression post-operative
5.19% for males aged 69 (±5) who have gerd and depression with bph and preventative

Hyperchlorhydria

6.16% for males aged 69 (±5) who have type i lipidaemia and reflux
6.16% for males aged 69 (±5) who have reflux and gas
6.16% for males aged 69 (±5) who have reflux and depression post-operative
6.16% for males aged 69 (±5) who have reflux and preventative
6.16% for males aged 69 (±5) who have gerd and exocrine pancreatic function test abnormal
6.16% for males aged 69 (±5) who have gerd and type i lipidaemia
6.16% for males aged 69 (±5) who have gerd and reflux
6.16% for males aged 69 (±5) who have gerd and gas
6.16% for males aged 69 (±5) who have gerd and depression post-operative
6.16% for males aged 69 (±5) who have gerd and preventative
6.16% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and reflux
5.92% for males aged 69 (±5) who have reflux and eczema
5.92% for males aged 69 (±5) who have gerd and eczema
5.29% for males aged 69 (±5) who have reflux and hypothyroidism
5.29% for males aged 69 (±5) who have gerd and hypothyroidism

Hyperlipidaemia

5.17% for males aged 69 (±5) who have bph and gas
5.17% for males aged 69 (±5) who have bph and depression post-operative
5.17% for males aged 69 (±5) who have bph and preventative
5.17% for males aged 69 (±5) who have exocrine pancreatic function test abnormal and bph
5.17% for males aged 69 (±5) who have bph and type i lipidaemia

Idiopathic pulmonary fibrosis

5.36% for males aged 69 (±5) who have bph and depression with gerd and exocrine pancreatic function test abnormal
5.36% for males aged 69 (±5) who have bph and depression with gerd and type i lipidaemia
5.36% for males aged 69 (±5) who have bph and depression with gerd and reflux
5.36% for males aged 69 (±5) who have bph and depression with gerd and gas
5.36% for males aged 69 (±5) who have bph and depression with gerd and depression post-operative
5.36% for males aged 69 (±5) who have bph and depression with gerd and preventative
5.36% for males aged 69 (±5) who have bph and depression with exocrine pancreatic function test abnormal and reflux
5.36% for males aged 69 (±5) who have bph and depression with type i lipidaemia and reflux
5.36% for males aged 69 (±5) who have bph and depression with reflux and gas
5.36% for males aged 69 (±5) who have bph and depression with reflux and depression post-operative
5.36% for males aged 69 (±5) who have bph and depression with reflux and preventative
5.13% for males aged 69 (±5) who have bph and depression with gerd and eczema
5.13% for males aged 69 (±5) who have bph and depression with reflux and eczema

Indigestion

28.58% for males aged 69 (±5) who have reflux and hypothyroidism
28.58% for males aged 69 (±5) who have gerd and hypothyroidism
24.91% for males aged 69 (±5) who have gerd and bph
24.91% for males aged 69 (±5) who have bph and reflux
5.51% for males aged 69 (±5) who have gerd and depression with hypothyroidism and gas
5.51% for males aged 69 (±5) who have gerd and depression with hypothyroidism and depression post-operative
5.51% for males aged 69 (±5) who have gerd and depression with hypothyroidism and preventative
5.51% for males aged 69 (±5) who have gerd and depression with exocrine pancreatic function test abnormal and hypothyroidism
5.51% for males aged 69 (±5) who have gerd and depression with type i lipidaemia and hypothyroidism

Metastatic renal cell carcinoma

13.24% for males aged 69 (±5) who have gerd and hypothyroidism with exocrine pancreatic function test abnormal and bph
13.24% for males aged 69 (±5) who have gerd and hypothyroidism with bph and type i lipidaemia
13.24% for males aged 69 (±5) who have gerd and hypothyroidism with bph and gas
13.24% for males aged 69 (±5) who have gerd and hypothyroidism with bph and depression post-operative
13.24% for males aged 69 (±5) who have gerd and hypothyroidism with bph and preventative

Multiple myeloma

5.36% for males aged 69 (±5) who take liothyronine sodium
5.36% for males aged 69 (±5) who take vitamins
5.36% for males aged 69 (±5) who take cetirizine hydrochloride allergy
5.36% for males aged 69 (±5) who take salviae miltiorrhizae
5.36% for males aged 69 (±5) who take peppermint oil
5.36% for males aged 69 (±5) who take tadalafil
5.36% for males aged 69 (±5) who take aspirin
5.36% for males aged 69 (±5) who take metformin hydrochloride
5.36% for males aged 69 (±5) who take levothyroxine thyroid
5.36% for males aged 69 (±5) who take alfuzosin hydrochloride
5.36% for males aged 69 (±5) who take lovastatin
5.36% for males aged 69 (±5) who take creon
5.36% for males aged 69 (±5) who take mirtazapine
5.36% for males aged 69 (±5) who take pantoprazole
5.36% for males aged 69 (±5) who take simethicone

Neuropathy peripheral

5.36% for males aged 69 (±5) who have bph and depression with gerd and exocrine pancreatic function test abnormal
5.36% for males aged 69 (±5) who have bph and depression with gerd and type i lipidaemia
5.36% for males aged 69 (±5) who have bph and depression with gerd and reflux
5.36% for males aged 69 (±5) who have bph and depression with gerd and gas
5.36% for males aged 69 (±5) who have bph and depression with gerd and depression post-operative
5.36% for males aged 69 (±5) who have bph and depression with gerd and preventative
5.36% for males aged 69 (±5) who have bph and depression with exocrine pancreatic function test abnormal and reflux
5.36% for males aged 69 (±5) who have bph and depression with type i lipidaemia and reflux
5.36% for males aged 69 (±5) who have bph and depression with reflux and gas
5.36% for males aged 69 (±5) who have bph and depression with reflux and depression post-operative
5.36% for males aged 69 (±5) who have bph and depression with reflux and preventative
5.13% for males aged 69 (±5) who have bph and depression with gerd and eczema
5.13% for males aged 69 (±5) who have bph and depression with reflux and eczema

Psoriasis

5.26% for males aged 69 (±5) who have bph and depression with hypothyroidism and eczema

Renal cell carcinoma

7.35% for males aged 69 (±5) who have gerd and hypothyroidism with exocrine pancreatic function test abnormal and bph
7.35% for males aged 69 (±5) who have gerd and hypothyroidism with bph and type i lipidaemia
7.35% for males aged 69 (±5) who have gerd and hypothyroidism with bph and gas
7.35% for males aged 69 (±5) who have gerd and hypothyroidism with bph and depression post-operative
7.35% for males aged 69 (±5) who have gerd and hypothyroidism with bph and preventative
6.1% for males aged 69 (±5) who have gerd and hypothyroidism with bph and eczema

Thrombosis

5.15% for males aged 69 (±5) who have gerd and hypothyroidism with hypothyroidism and eczema

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used, and more. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

Related publications that referenced our studies

Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
T.Audi Yanto, I.Huang, F.Nathania Kosasih, NP Hardjo Lugito, "Nightmare and Abnormal Dreams: Rare Side Effects of Metformin?", Case Reports in Endocrinology, 2018 Jan .
Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Al-Hamdy RA, "Assessment of electrolytes and HbA1c in type 2 diabetic patients using metformin and evaluation of guidelines obedience regarding renal impairment", J.Thi-Qar Sci., 2015 Jan .
Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
Wiwanitkit S, Wiwanitkit V, "Metformin and sleep disorders", Indian journal of endocrinology and metabolism, 2012 Jan .

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.